NORMAN, Okla. (Legal Newsline) - Admitting there is a high potential for abuse in opioid medications, Johnson & Johnson attorney Larry Ottaway said during opening arguments on Tuesday that physicians prescribing its medications Nucynta and Duragesic know this risk and have to know it to be licensed.
In most use cases, we are told, there exists no viable alternative to PFAS, which portends the real potential outrage here. In the end, banning PFAS would mean consumers would be deprived of their iPhones and pharmaceuticals; it would make air travel less safe and automobiles more polluting.
NORMAN, Okla. (Legal Newsline) – Fighting back tears, a father who lost his son to an opioid overdose recounted the nightmare during testimony in a trial alleging that Johnson & Johnson flooded the state with addictive drugs for profit.
NORMAN, Okla. (Legal Newsline) - Cleveland County District Judge Thad Balkman overruled several objections made by Johnson & Johnson/Janssen Pharmaceuticals (J&J) as the second day of trial unfolded in the state's pursuit of abatement in what it calls a man-made opioid crisis.
WILLIAMSON – Don Blankenship has filed a third defamation lawsuit in as many months, this time singling out The Boston Globe for being involved in a conspiracy to keep him from being elected in 2018 to the U.S. Senate.
NORMAN (Legal Newsline) – A corporate spokeswoman for Johnson & Johnson and its drug subsidiary Janssen Pharmaceuticals on Thursday faced questioning by lawyers for the State of Oklahoma who attempted to link the company’s quest for profits to an opioid epidemic in the state.
NORMAN, Okla. (Legal Newsline) - Tensions ran high in court Thursday as the Oklahoma opioid trial continued, with defense attorney Larry Ottoway objecting throughout the day to opposing counsel's line of questioning directed at defense witness, business director for Janssen Pharmaceuticals Kimberly Deem-Eshleman.